Articles On Patrys (ASX:PAB)

The ASX 200 got over the line again for another daily win, despite curbed afternoon enthusiasm Traders, investors, companies and pretty much anyone who cares about the economic state of the world await the next highwire act in The Trump Ta...

ASX rebounds 1pc with tech and real estate leading the way Nanosonics jumps  after FDA gives approval Aussie job numbers dip, fuelling rate cut hopes   The ASX had a cracker of a session on Thursday, up by 1.2% as it registered the best o...

ASX recovers from morning loss but tech sector hammered Tesla drops 15pc, Bitcoin struggles Star entertainment looks for $940m lifeline   The ASX had a (very) bumpy day on Tuesday, with$20 billion wiped out at one point, before it recover...

ASX bounces back but still under 8k mark Big moves in ASX 200 rebalance Cyclone Alfred eases, insurers up, Johns Lyng drops   The ASX managed to eke out a small gain on Monday, edging higher  by 0.18% after taking a dive to a six-month lo...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

The Nasdaq-listed Gelteq has mastered pouch delivery for people who find it difficult to swallow ASX IPO candidate Vaxxas is working on the needle-less delivery of vaccines ASX companies including LTR Pharma and Wellnex Life have devised a...

ASX rebounds as real estate, miners rise NRW Holdings slumps over Whyalla collapse mess Insurers hit hard as Cyclone Alfred looms   The ASX bounced back by 0.90% on Monday, shaking off the losses from last week even as the threat of loomi...

Highlights: Revenue experienced an increase compared to the same period last year Net loss showed a notable decline, reflecting improved financial performance Shares experienced an upward trend over the past week Patrys Limited (A...

Telix expects three more US product approvals this year Patrys switches to plan B Biotron’s do-or-die $500,000 capital raising   Analysts reckon Telix Pharmaceuticals (ASX:TLX) has only just started to reach its full potential, with three...

ASX closes in green after reaching new record high in morning trade Staples and tech stocks felt the love on Valentine’s Day Energy stocks and healthcare, however, got cold feet. Or the cold shoulder. Maybe both   The ASX leapt out of bed...

ASX jumps on strong banks and jobs report Zip and Tabcorp surge as markets rally Oil prices soar amid supply risks and cold weather   The ASX flexed its muscles today, up 1.38% on the back of strong bank gains and a bit of global risk-on...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

ASX rises as oil, uranium supply issue boosts stocks Aussie dollar slips while gold, real estate gain Tesla drags Wall Street down   The ASX defied Wall Street’s gloom, roaring higher for a second day in 2025 as soaring oil prices and a h...

ASX closes lower on last day of 2024 Bitcoin wobbles, Aussie dollar weakens Mesoblast bucks trend with 10pc rise   It’s the last trading day of 2024, and the ASX has gone out with a whimper. After a rough start on Tuesday, the ASX closed...

ASX gives back gains ahead of Fed decision Vulcan and DigiCo rise MinRes completes $780m gas deal with Hancock Prospecting   The ASX gave back its earlier gains this afternoon as investors adopted a more cautious approach ahead of the US...

 Percheron’s Duchenne muscular dystrophy trial has been a compete flop Canaccord Genuity says Opthea shares are worth at least double their current price Neurizon asks US regulator for motor neurone disease trial go-ahead   Firstly, full...

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

ASX drops to 4-week low, miners lead losses Rio Tinto slumps after $2.5bn lithium investment, iron ore prices fall DigiCo REIT slips on IPO debut   The ASX has closed lower by 0.4% on Friday to near its lowest level in a month. For the we...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

The S&P/ASX 200 rose 4% in November to a new record high of 8436.23 points as volatility fell following US election Information Technology led the gainers rising 10% in November and remained top performer YTD, up 56.79%  NoviqTech rose...

ASX loses momentum after near-record high Tech stocks lead, but CSL falls; retail sales rise 0.6% in October Northern Star to buy De Grey for $5 billion   The ASX has lost some of its early momentum today, pulling back from a record high...

ASX rises on rally across the board Israel and Hezbollah agree to 60-day ceasefire City Chic tumbles after downbeat update   The Aussie share market enjoyed a solid ride on Wednesday, driven by a broad rally as optimism from Wall Street’s...

Chinese shoppers have not lost their appetite for EZZ’s health and beauty products Ho-Ho-Ho (Chi Minh)! Viet deal is an early Xmas prez for Truscreen holders Patrys says it will focus on its Plan B drug candidate   China is a tough consum...

Highlights    Enhanced understanding of SCLC subtypes drives tailored treatment approaches.   Immunotherapy and antibody-drug conjugates emerge as key strategies.   Asia-Pacific region identified as a critical area for further clinica...

ASX starts week lower with mining stocks under pressure Resolute mining plunges after CEO detained in Mali Bitcoin surges past US$81k as Trump’s win fuels optimism   The ASX had a rough start to the week, with mining stocks dragging the m...

ASX rallies broadly as tech stocks lead Commonwealth Bank hits record, Neuren jumps Asian markets rise, China stimulus eyed   The ASX was riding the coattails of a strong Wall Street session, with tech stocks leading the charge.  At the c...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

The S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones Indices said financials led the gains in October and is up 30% YTD Ovanti rose 525% in October after appointment of former Zip US CFO Simon K...

ASX opens November lower, led by financial sector sell-off Macquarie Group fell after profit decline Ironbark Zinc jumps 75% on new leadership   The ASX kicked off November with a thud, sliding about 0.5%. This  follows a tough session o...

  ASX slips  amid earnings updates and company meetings AGL drops over 6pc after downgrade, while Origin Energy rises Talga surges after Sweden approves graphite mine   The ASX slipped by 0.22% after being dragged by a flurry of company...

ASX rises  following Wall Street’s lead Cettire drops 12pc after disappointing earnings update Retail house Premier Investments surge after potential Myer deal   The ASX rose by 0.34% on Tuesday following Wall Street’s lead. Consumer dis...

ASX gains  as energy and mining stocks rally Arcadium Lithium surges  after Rio acquisition, while GYG reports strong Q1 Hurricane Milton lands and pushes oil prices higher   The ASX gained ground by 0.3% on Thursday and neared its recor...

ASX fell as mining stocks dropped on China’s lack of stimulus Brent oil dipped below US$80 Big lithium stocks fall, but smaller players keep gaining after Rio Tinto’s Arcadium takeover talks   The ASX closed lower by 0.35% in a volatile...

  ASX 200 index falls despite gains in energy stocks Smaller oil and gas firms benefit from rising crude prices Iron ore stocks drop as prices retreat   The ASX 200 index fell hard on Friday, down by 0.75%, despite some gains in the Ener...

    ASX edges down in a quiet market Pilbara Minerals falls 5pc as share block sale is reported Westpac sells auto finance unit for up to $1.6 billion   The ASX has lifted slightly on Thursday, up by 0.1%, as traders remain cautious amid...

Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

  ASX flattish amid rising Middle East tensions Crude oil prices surge 5pc, pushing oil stocks higher Gold miners gain as investors seek safe havens   The ASX shifted from early gains to a mostly flat finish as investors turned to safer...

Argent Biopharma packs its bags for London on a one-way ticket Patrys shares slump 50% on cancellation of key drug program Painchek targets US market for its pain detection app   Health Check is renowned biotech journo Tim Boreham’s daily...

Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX200 hits record high driven by US Fed interest rate cut Mining stocks surge as iron ore prices rebound ALS shares drop 10pc, Monadelphous rises on new contracts   The ASX200 hit yet another record high today, boosted by the first inte...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

ASX up as earnings season rolls on; Origin down 10pc, Telstra up 3pc Australia’s unemployment rate edged up to 4.2pc from 4.1pc Iron ore futures dropped below US$94 per ton   The ASX edged slightly higher by 0.1% on Thursday, boosted by a...

ASX rises circa 0.5pc Consumer stocks in focus this week SGQ and PHX lead small caps   Aussie stocks have closed higher on Monday as IT and retail stocks added strength to sentiment. The S&P/ASX200 closed higher, gaining 36.00 points...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Good morning, and welcome to Stockhead’s Top 10 at shortly-after-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the t...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...